TEVA - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 87352574
Serial Number
87352574
Word Mark
TEVA
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2021-03-29
Filing Date
2017-02-28
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
050308, 050325, 260106, 260113, 260116, 260902, 270304 - More than one leaf, including scattered leaves, bunches of leaves not attached to branches. Other leaves. Semi-circles. Two circles. Circles touching or intersecting. Plain single line squares. Representations of plants or parts of plants forming letters or numerals, including punctuation.
Published for Opposition Date
2017-12-26
Attorney Name
Laurence Rickles
Law Office Assigned Location Code
L10
Employee Name
MICHELI, ANGELA M
Statements
Indication of Colors claimed
The color(s) dark green, light green, white and gray is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a light green design that begins at the bottom left hand corner and rises up to the upper right hand corner. This light green continues in a straight light across the top. There are 2 darker green half circles at the bottom right hand corner that when they intersect make a dark green. In the dark green intersection at the bottom right hand corner is the word "teva" in lower case white letters. The "v" in the word "teva" is formed by 2 leaf shapes. The color white also appears in the rectangle created by the gray outlining the entire mark. The entire mark is outlined by a thin gray line.
Goods and Services
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Translation of Words in Mark
The English translation of "TEVA" in the mark is "NATURE".
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-03-07
Primary Code
005
Correspondences
Name
Laurence Rickles
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2017-03-03NEW APPLICATION ENTERED IN TRAM
2017-03-07NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-03-08NOTICE OF DESIGN SEARCH CODE E-MAILED
2017-05-23ASSIGNED TO EXAMINER
2017-05-26PRIORITY ACTION WRITTEN
2017-05-26PRIORITY ACTION E-MAILED
2017-05-26NOTIFICATION OF PRIORITY ACTION E-MAILED
2017-11-14TEAS RESPONSE TO OFFICE ACTION RECEIVED
2017-11-14CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-11-14TEAS/EMAIL CORRESPONDENCE ENTERED
2017-11-17EXAMINERS AMENDMENT -WRITTEN
2017-11-17EXAMINERS AMENDMENT E-MAILED
2017-11-17NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2017-11-17EXAMINER'S AMENDMENT ENTERED
2017-11-17APPROVED FOR PUB - PRINCIPAL REGISTER
2017-12-06NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-12-26PUBLISHED FOR OPPOSITION
2017-12-26OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-02-20NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-08-13TEAS EXTENSION RECEIVED
2018-08-13EXTENSION 1 FILED
2018-08-13EXTENSION 1 GRANTED
2018-08-15NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-02-13TEAS EXTENSION RECEIVED
2019-02-13EXTENSION 2 FILED
2019-02-13EXTENSION 2 GRANTED
2019-02-15NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-08-13TEAS EXTENSION RECEIVED
2019-08-13EXTENSION 3 FILED
2019-08-13EXTENSION 3 GRANTED
2019-08-15NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-02-19TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-02-19TEAS EXTENSION RECEIVED
2020-02-19EXTENSION 4 FILED
2020-02-19EXTENSION 4 GRANTED
2020-02-29NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-08-13TEAS EXTENSION RECEIVED
2020-08-18CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-08-13EXTENSION 5 FILED
2020-08-21EXTENSION 5 GRANTED
2020-08-22NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-03-29ABANDONMENT - NO USE STATEMENT FILED
2021-03-29ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED